Current Pharmaceutical Design
Title:Editorial: (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze)
Volume: 21 Issue: 23
Author(s): Benjamin Rolland and Ali Amad
Affiliation:
Export Options
About this article
Cite this article as:
Rolland Benjamin and Amad Ali, Editorial: (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze), Current Pharmaceutical Design 2015; 21 (23) . https://dx.doi.org/10.2174/138161282123150723153610
DOI https://dx.doi.org/10.2174/138161282123150723153610 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Aquaporin and Blood Brain Barrier
Current Neuropharmacology From Protein-Protein Interactions to Rational Drug Design: Are Computational Methods Up to the Challenge?
Current Topics in Medicinal Chemistry Melatonin Prevents Neddylation Dysfunction in Aβ42-Exposed SH-SY5Y Neuroblastoma Cells by Regulating the Amyloid Precursor Protein- Binding Protein 1 Pathway
Current Alzheimer Research Synthesis and Biological Evaluation of Curcumin-Nitroxide-Based Molecular Hybrids as Antioxidant and Anti-Proliferative Agents
Medicinal Chemistry Analyses of Associations Between Reactive Oxygen Metabolites and Antioxidant Capacity and Related Factors Among Healthy Adolescents
Current Aging Science Synthesis and Antibacterial and Antifungal Activity of 5-Substituted Imidazolones
Letters in Drug Design & Discovery Conference Report: 184th American Association for the Advancement of Science Annual Meeting, Austin TX, USA Feb. 15-19, 2018
CNS & Neurological Disorders - Drug Targets Ageing and Nutritional Therapy Adherence in Type 2 Diabetes
Current Diabetes Reviews 5-HT7 Receptor Ligands: Recent Developments and Potential Therapeutic Applications
Mini-Reviews in Medicinal Chemistry Brain Network Connectivity Mediates Education-related Cognitive Performance in Healthy Elderly Adults
Current Alzheimer Research Microwave-Assisted Chemistry of 2(1H)-pyrazinones
Current Organic Chemistry Is there Any Correlation Between Binding and Functional Effects at the Translocator Protein (TSPO) (18 kDa)?
Current Molecular Medicine Tryptophan Catabolites and Migraine
Current Pharmaceutical Design Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale
Current Organic Chemistry Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
CNS & Neurological Disorders - Drug Targets Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture
CNS & Neurological Disorders - Drug Targets Quadruplex DNA: A Promising Drug Target for the Medicinal Inorganic Chemist
Current Topics in Medicinal Chemistry Telomeres, Telomerase and Malignant Transformation
Current Molecular Medicine